Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1999 Apr;52(2):84–91. doi: 10.1136/mp.52.2.84

Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression.

B Perbal 1
PMCID: PMC395679  PMID: 10474687

Abstract

AIMS: To identify the NOV protein detected by immunofluorescence in the nucleus of human cancer cell lines to establish whether targeting to the nucleus reflects dual paracrine and intracrine biological functions of NOV, as has been reported previously for several signalling peptides and proteins. METHODS: Nuclear and cytoplasmic fractions were prepared from 143 and HeLa cells in which nuclear NOV protein was detected. Western blotting analysis of NOV proteins in both types of fractions was performed using two NOV specific antibodies. Confocal microscopy was used to visualise the nuclear NOV protein in HeLa and 143 cells. A yeast two hybrid screening system was used to isolate cDNAs encoding proteins able to interact with the human NOV protein. RESULTS: A 31/32 kDa doublet of NOV protein was identified in the nuclear fraction of 143 and HeLa cells. Because the antibodies were directed against the C-terminus of NOV, the 31/32 kDa NOV isoform is probably truncated at the N-terminus and might correspond to the secreted 32 kDa NOV isoform detected in cell culture medium. Confocal microscopy indicated that in addition to the cytoplasmic NOV protein already identified, a nuclear NOV protein was present in both the nucleoplasm and nucleoli of Hela and 143 cells. Screening of cDNA libraries prepared from HeLa cells, Epstein-Barr virus transformed lymphocytes, and normal human brain showed that the NOV protein interacts with the rpb7 subunit of RNA polymerase in a yeast two hybrid system. CONCLUSIONS: The NOV protein detected in the nucleus of 143 and HeLa cells is probably an N-terminus truncated isoform of the secreted 48 kDa NOV protein. A growing body of evidence suggests that novH expression is closely associated with differentiation in normal human tissues and that the nov gene encodes a signalling protein that belongs to an emerging family of cell growth regulators. The nuclear localisation of a NOV isoform potentially provides an additional degree of signalling specificity. The interaction of the NOV protein and the rpb7 subunit of RNA polymerase II in the two hybrid system suggests that NOV might be involved in regulating gene expression at the transcriptional level. As has already been suggested for several other nuclearly located cytokines, the NOV protein does not contain a typical nuclear localisation signal. Therefore, it is possible that it combines with either a receptor or a chaperone during its translocation. Disruption of the balance between the secreted and nuclear NOV isoforms might affect the putative autocrine and paracrine functions of NOV and might be of considerable importance in the development of cancers in which the expression of novH has been shown to be impaired.

Full Text

The Full Text of this article is available as a PDF (274.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoine M., Reimers K., Dickson C., Kiefer P. Fibroblast growth factor 3, a protein with dual subcellular localization, is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal. J Biol Chem. 1997 Nov 21;272(47):29475–29481. doi: 10.1074/jbc.272.47.29475. [DOI] [PubMed] [Google Scholar]
  2. Chevalier G., Yeger H., Martinerie C., Laurent M., Alami J., Schofield P. N., Perbal B. novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol. 1998 Jun;152(6):1563–1575. [PMC free article] [PubMed] [Google Scholar]
  3. Henderson J. E. Nuclear targeting of secretory proteins. Mol Cell Endocrinol. 1997 Apr 25;129(1):1–5. doi: 10.1016/s0303-7207(97)04021-5. [DOI] [PubMed] [Google Scholar]
  4. Jaques G., Noll K., Wegmann B., Witten S., Kogan E., Radulescu R. T., Havemann K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology. 1997 Apr;138(4):1767–1770. doi: 10.1210/endo.138.4.5177. [DOI] [PubMed] [Google Scholar]
  5. Joliot V., Martinerie C., Dambrine G., Plassiart G., Brisac M., Crochet J., Perbal B. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol. 1992 Jan;12(1):10–21. doi: 10.1128/mcb.12.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kim H. S., Nagalla S. R., Oh Y., Wilson E., Roberts C. T., Jr, Rosenfeld R. G. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12981–12986. doi: 10.1073/pnas.94.24.12981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lalou C., Lassarre C., Binoux M. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology. 1996 Aug;137(8):3206–3212. doi: 10.1210/endo.137.8.8754741. [DOI] [PubMed] [Google Scholar]
  8. Lalou C., Sawamura S., Segovia B., Ogawa Y., Binoux M. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. C R Acad Sci III. 1997 Aug;320(8):621–628. doi: 10.1016/s0764-4469(97)85695-8. [DOI] [PubMed] [Google Scholar]
  9. Li W., Fawcett J., Widmer H. R., Fielder P. J., Rabkin R., Keller G. A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology. 1997 Apr;138(4):1763–1766. doi: 10.1210/endo.138.4.5176. [DOI] [PubMed] [Google Scholar]
  10. Martinerie C., Huff V., Joubert I., Badzioch M., Saunders G., Strong L., Perbal B. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene. 1994 Sep;9(9):2729–2732. [PubMed] [Google Scholar]
  11. Martinerie C., Viegas-Pequignot E., Guenard I., Dutrillaux B., Nguyen V. C., Bernheim A., Perbal B. Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene. 1992 Dec;7(12):2529–2534. [PubMed] [Google Scholar]
  12. Martinerie C., Viegas-Pequignot E., Nguyen V. C., Perbal B. Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol. 1997 Dec;50(6):310–316. doi: 10.1136/mp.50.6.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. O'Brien T. P., Yang G. P., Sanders L., Lau L. F. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol. 1990 Jul;10(7):3569–3577. doi: 10.1128/mcb.10.7.3569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Perbal B. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development. Crit Rev Oncog. 1994;5(6):589–613. [PubMed] [Google Scholar]
  15. Perbal B. Pathogenic potential of myeloblastosis-associated viruses. Infect Agents Dis. 1995 Dec;4(4):212–227. [PubMed] [Google Scholar]
  16. Ryseck R. P., Macdonald-Bravo H., Mattéi M. G., Bravo R. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 1991 May;2(5):225–233. [PubMed] [Google Scholar]
  17. Schedlich L. J., Young T. F., Firth S. M., Baxter R. C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem. 1998 Jul 17;273(29):18347–18352. doi: 10.1074/jbc.273.29.18347. [DOI] [PubMed] [Google Scholar]
  18. Scholz G., Martinerie C., Perbal B., Hanafusa H. Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol. 1996 Feb;16(2):481–486. doi: 10.1128/mcb.16.2.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Simmons D. L., Levy D. B., Yannoni Y., Erikson R. L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1178–1182. doi: 10.1073/pnas.86.4.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Snaith M. R., Natarajan D., Taylor L. B., Choi C. P., Martinerie C., Perbal B., Schofield P. N., Boulter C. A. Genomic structure and chromosomal mapping of the mouse nov gene. Genomics. 1996 Dec 15;38(3):425–428. doi: 10.1006/geno.1996.0647. [DOI] [PubMed] [Google Scholar]
  21. Su B. Y., Cai W. Q., Zhang C. G., Su H. C., Perbal B. A developmental study of novH gene expression in human central nervous system. C R Acad Sci III. 1998 Nov;321(11):883–892. doi: 10.1016/s0764-4469(99)80002-x. [DOI] [PubMed] [Google Scholar]
  22. Ying Z., King M. L. Isolation and characterization of xnov, a Xenopus laevis ortholog of the chicken nov gene. Gene. 1996 Jun 1;171(2):243–248. doi: 10.1016/0378-1119(95)00891-8. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES